Navigation Links
New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
Date:5/20/2008

A Separate Retrospective Analysis of US Employer Claims Suggests a Benefit of Anti-Tumor Necrosis Factor Therapies on Absenteeism Among Employees with

Inflammatory Bowel Disease

SAN DIEGO, May 20 /PRNewswire/ -- Data from a new analysis of the Active Ulcerative Colitis Trials (ACT 1 and ACT 2) showed that at week 8, more than 60 percent of patients with moderately to severely active ulcerative colitis (UC) receiving REMICADE(R) (infliximab) achieved clinical response regardless of disease duration (less than three years versus at least three years). Investigators also reported that at week 30, significant improvements were maintained with nearly half of REMICADE-treated patients having a clinical response. Significant improvements in disease remission and mucosal healing were also reported at weeks 8 and 30 among patients receiving REMICADE and meeting the disease duration criteria. These findings were presented today at the annual Digestive Disease Week(R) (DDW) meeting.

"These data are encouraging because we see that REMICADE is an effective treatment option for patients with active ulcerative colitis, whether recently diagnosed or struggling with the condition for many years," said Dr. Bruce Sands, Associate Professor of Medicine at Harvard Medical School, and study investigator. "Regardless of disease duration, patients receiving REMICADE showed significant improvements in clinical response, remission and mucosal healing, all goals of therapy in the treatment of ulcerative colitis."

In the analysis of 728 patients from ACT 1 and ACT 2, 254 patients had UC for less than three years and 474 patients had UC for at least three years. Clinical response, clinical remission and mucosal healing rates at week 8 for the combined REMICADE treatment group (5 mg/kg and 10 mg/kg) were all significantly higher than the placebo group (P < 0.01) regardless of disease duration; clinical response: 62 percent versus 33 percent for
'/>"/>

SOURCE Centocor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)...  CVS Health is thanking its 26,000 pharmacists during ... the way health care is delivered to increase access, ... pharmacies, mail service pharmacies and specialty pharmacies nationwide.  ... to CVS Health to reflect our broader health care ... to shape the future of health," said Larry ...
(Date:9/30/2014)... 30, 2014 This report analyzes the worldwide markets ... Product Categories: Enteral Feeding Pumps, Nasogastric Tubes, and Others. ... Canada, Japan , Europe ... , and Rest of World. Annual estimates and forecasts ... six-year historic analysis is provided for these markets. ...
(Date:9/30/2014)... , Sept. 30, 2014  Tasly Pharmaceuticals, Inc., ... modernize medicine, announced today the launch of Deepure. ... developed to address men and women concerned with ... vibrant into old age while helping keep their ... condition-specific, whole-food and herb-based formulas, namely, ProHeart PLUS, ...
Breaking Medicine Technology:CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 2CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 3Global Enteral Feeding Devices Industry 2Global Enteral Feeding Devices Industry 3Global Enteral Feeding Devices Industry 4Global Enteral Feeding Devices Industry 5Global Enteral Feeding Devices Industry 6Global Enteral Feeding Devices Industry 7Global Enteral Feeding Devices Industry 8Global Enteral Feeding Devices Industry 9Global Enteral Feeding Devices Industry 10Global Enteral Feeding Devices Industry 11Global Enteral Feeding Devices Industry 12Global Enteral Feeding Devices Industry 13Global Enteral Feeding Devices Industry 14Global Enteral Feeding Devices Industry 15Global Enteral Feeding Devices Industry 16Global Enteral Feeding Devices Industry 17Global Enteral Feeding Devices Industry 18Global Enteral Feeding Devices Industry 19
... Inc. (Nasdaq: DCTH ) announced today that it has ... common stock at $3.60 per share, or $30.6 million, pursuant ... the Company has granted the underwriters of the offering an ... primary stock to cover over-allotments. The offering is expected ...
... NEW YORK, Nov. 12 Reportlinker.com announces ... available in its catalogue. , ... to 2015 , ... Market Analysis & Forecasts to 2015 , ...
Cached Medicine Technology:Delcath Systems, Inc. Prices $30.6 Million Stock Offering 2Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 2Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 3Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 4Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 5Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 6Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 7Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 8Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 9Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 10Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 11Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 12Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 13Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 14Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 15Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 16Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 17
(Date:10/1/2014)... Bedros Keuilian is not only the ... boot camps, he’s also considered the leading expert on ... out business summits, a line of high-demand fitness marketing ... recent Spike TV reality show to his name. , ... time for personal trainers and fitness business owners to ...
(Date:10/1/2014)... 01, 2014 First Warning Systems, a ... cellular changes throughout the body, announced the company is ... address the company’s breadth of upcoming product releases. The ... screening technology. , “Our initial focus will be an ... detects abnormal circadian cellular changes over time,” said Rob ...
(Date:10/1/2014)... D.C. and ATLANTA (PRWEB) October 01, 2014 ... information security executive networking and relationship-marketing firm, ... 2014 Information Security Executive® and Project of ... include top-ranking decision makers representing organizations in ... academics. Projects include large-scale technology endeavors that ...
(Date:10/1/2014)... 01, 2014 Join the more than 80 ... Treatment Center’s first ever charity golf tournament to benefit Project ... eating disorders who cannot afford treatment. The tournament will be ... Eureka, Mo. , The day-long event starts with 10:30 ... and award dinner will begin at 5 p.m. and will ...
(Date:10/1/2014)... Beverly Hills, California (PRWEB) October 01, 2014 ... relationship expert, Dr. Kathleen Mojas is celebrating 20 years ... she has assisted hundreds of people to achieve greater ... released an important list of warning signs and suggestions ... relationship. , Dr. Mojas explains: “Believe it or ...
Breaking Medicine News(10 mins):Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3
... Addition of intravenous magnesium sulfate to standard emergency ... rather than enhance the effectiveness of treatment.// Dr. ... College of Medicine in the Bronx, New York, ... be helpful in the treatment of migraine headache ...
... in animal products raises the risk of breast cancer, ... suggested a link between a high fat diet, rich ... based in Chicago, USA, reveals that dietary differences might ... high where the proportion of daily calories from animal ...
... killer, accounting for one in four deaths, more than ... that the diversity of lung disease has yet to ... deal only in one disorder, chest physicians look after ... asthma, pneumonia, cystic fibrosis and sleep apnoea. There are ...
... complications in ovarian cancer. A gene implicated in inherited ovarian ... Up to 10 per cent of cases of ovarian cancer ... these cases, the woman usually has a strong family history ... developing, although it's not yet known in detail how it ...
... year worldwide if more people at high risk of having ... An analysis of nearly 300 clinical trials of aspirin and ... that aspirin reduces heart attacks and strokes in susceptible patients. ... from aspirin and anti-platelet therapy receive it. ,“This ...
... at Hopkins University, they have found a way to use ... system, surpassing an obstacle to certain forms of gene ... body's immune response to developing cancer vaccines to reducing the ... core of the blood system.// They can give rise to ...
Cached Medicine News:Health News:A new study surpasses Gene Therapy Hurdle 2
SATOs Neonatal Secure ID bands are your answer to comfort and safe patient identification of neonatal patients and newborns. Comfortable, yet durable, they display the patient and parent detail you d...
Platelet Aggregation Profiler...
... need to be a pain in the neck. ... longer handle to reduce the amount of arm ... with a conventional pipettor. The ergonomic design includes ... stand which enables the unit to be set ...
... all-new Assure Pro Blood Glucose Monitoring System ... of the Long-Term Care profession. More features ... strip release offer better convenience, safety, and ... test strip in the convenient top-of-the-meter port. ...
Medicine Products: